HCN has been the subject of a number of other recent research reports. Analysts at Raymond James raised their price target on shares of Health Care REIT from $63.50 to $67.00 in a research note to investors on Wednesday, February 27th. They now have an outperform rating on the stock. Separately, analysts at Barclays Capital reiterated an overweight rating on shares of Health Care REIT in a research note to investors on Wednesday, February 27th. They now have a $70.00 price target on the stock, down previously from $71.00. Finally, analysts at Stifel Nicolaus raised their price target on shares of Health Care REIT from $64.00 to $67.00 in a research note to investors on Tuesday, February 26th. They now have a buy rating on the stock.
Six analysts have rated the stock with a buy rating, one has issued an overweight rating, nine have given a hold rating, and two have given a sell rating to the stock. The stock currently has a consensus rating of hold and an average price target of $63.57.
Shares of Health Care REIT opened at 64.62 on Thursday. Health Care REIT has a one year low of $52.40 and a one year high of $64.87. The stock’s 50-day moving average is currently $62.86. The company has a market cap of $16.755 billion and a P/E ratio of 65.80.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.